NHS commercial framework for new medicines

This document outlines the purpose and principles on which NHS commercial medicines activity will be based, defining the roles and responsibilities of those involved in commercial medicines activity and detailing how pharmaceutical companies can engage with the NHS.

SPS commentary:

NHS England and NHS Improvement previously asked for comments on their proposed NHS commercial framework for new medicines and have published a document that summarises the feedback and outlines the changes made to the framework in response to this.


NHS England

Resource links:

NHSE/I response to engagement